These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 9033918
21. [New antibacterial agents]. Järvinen A, Valtonen V. Duodecim; 2000; 116(24):2803-5. PubMed ID: 12077883 [No Abstract] [Full Text] [Related]
22. [New quinolones for the treatment of community-acquired pneumonia--contra]. Egger M. Dtsch Med Wochenschr; 2003 May 09; 128(19):1071. PubMed ID: 12736860 [No Abstract] [Full Text] [Related]
23. Optimisation of antibiotic therapy in cystic fibrosis patients. Pharmacokinetic considerations. Lindsay CA, Bosso JA. Clin Pharmacokinet; 1993 Jun 09; 24(6):496-506. PubMed ID: 8513651 [Abstract] [Full Text] [Related]
24. Pharmacokinetics of antibiotics in burn patients. Weinbren MJ. J Antimicrob Chemother; 1999 Sep 09; 44(3):319-27. PubMed ID: 10511398 [Abstract] [Full Text] [Related]
26. Therapeutic monitoring, the concentration-effect relationship and impact on the clinical efficacy of antibiotic agents. Dawson SJ, Reeves DS. J Chemother; 1997 May 09; 9 Suppl 1():84-92. PubMed ID: 9248966 [Abstract] [Full Text] [Related]
27. [Recent advance of anti-tuberculous agents]. He G, Xiao H. Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct 09; 23(10):621-5. PubMed ID: 11372389 [No Abstract] [Full Text] [Related]
28. Intraphagocytic penetration of antibiotics. Van der Auwera P, Matsumoto T, Husson M. J Antimicrob Chemother; 1988 Aug 09; 22(2):185-92. PubMed ID: 2846489 [Abstract] [Full Text] [Related]
29. [Pneumonia due to Legionella. Macrolides or quinolones?]. Gómez J, Ruiz Gómez J, Sabrià M. Rev Esp Quimioter; 2002 Mar 09; 15(1):21-4. PubMed ID: 12582433 [No Abstract] [Full Text] [Related]
30. [Significance of pharmacokinetics, pharmacodynamics and administration form of antibiotics for effective treatment of infections]. Mattie H, Bakker-Woudenberg IA, Koopmans PP. Ned Tijdschr Geneeskd; 1992 Apr 18; 136(16):772-5. PubMed ID: 1574146 [No Abstract] [Full Text] [Related]
31. Kinetics and quantification of antibacterial effects of beta-lactams, macrolides, and quinolones against gram-positive and gram-negative RTI pathogens. Schaper KJ, Schubert S, Dalhoff A. Infection; 2005 Dec 18; 33 Suppl 2():3-14. PubMed ID: 16518706 [Abstract] [Full Text] [Related]
32. Antibiotic penetration in the respiratory tract and implications for the selection of antimicrobial therapy. Honeybourne D. Curr Opin Pulm Med; 1997 Mar 18; 3(2):170-4. PubMed ID: 9193864 [Abstract] [Full Text] [Related]
33. [Pharmacokinetics of antibiotics in burn patients]. Lesne-Hulin A, Bourget P, Carsin H. Therapie; 1995 Mar 18; 50(6):575-86. PubMed ID: 8745959 [Abstract] [Full Text] [Related]
34. Synergistic antibacterial activity of cefotaxime and the penem HRE 664 in an improved in vitro model simulating serum and tissue pharmacokinetics. Isert D, Klesel N, Markus A, Seibert G, Schrinner E. J Chemother; 1989 Jul 18; 1(4 Suppl):479-81. PubMed ID: 16312493 [No Abstract] [Full Text] [Related]
35. The importance of pharmacokinetics and pharmacodynamics for effective treatment of infections. Mattie H. Clin Investig; 1993 Jun 18; 71(6):480-2. PubMed ID: 8394759 [No Abstract] [Full Text] [Related]
36. [Pharmacodynamic assessment of antibiotic sensitivity of Streptococcus pneumoniae]. Soriano F. Med Clin (Barc); 1999 Jun 26; 113(3):103-8. PubMed ID: 10464745 [No Abstract] [Full Text] [Related]
37. [Pharmacokinetic effects of antibiotics on the development of bacterial resistance particularly in reference to azithromycin]. Wenisch C. Wien Med Wochenschr; 2000 Jun 26; 150(3):37-41. PubMed ID: 10756595 [Abstract] [Full Text] [Related]
38. Unique aspects of quinolone pharmacokinetics. Lode H, Höffken G, Borner K, Koeppe P. Clin Pharmacokinet; 1989 Jun 26; 16 Suppl 1():1-4. PubMed ID: 2653691 [Abstract] [Full Text] [Related]
39. Antibiotics in older adults. Rodríguez-Julbe MC, Ramírez-Ronda CH, Arroyo E, Maldonado G, Saavedra S, Meléndez B, González G, Figueroa J. P R Health Sci J; 2004 Mar 26; 23(1):25-33. PubMed ID: 15125216 [Abstract] [Full Text] [Related]
40. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside]. Mimoz O, Grollier G. Ann Fr Anesth Reanim; 2004 Jun 26; 23(6):639-42. PubMed ID: 15234735 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]